Toward operative in vivo fluorescence imaging of the c‐Met proto‐oncogene for personalization of therapy in ovarian cancer
<p style="text-align:justify;"> <b>BACKGROUND:</b> Standard biomarker testing of a single macroscopic disease site is unlikely to be sufficient because of tumor heterogeneity. A focus on examining global biomarker expression or activity, particularly in microscopic resid...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2014
|